NCT03444480View on ClinicalTrials.gov

A Phase Ⅰb Study of Remimazolam Tosylate in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

July 23, 2014

Primary Completion Date

August 16, 2014

Study Completion Date

August 16, 2014

Conditions
Anesthesia
Interventions
DRUG

Remimazolam Tosylate

Initial dose plus supplemental doses

Trial Locations (1)

100032

Peking Union Medical College Hospital, Beijing

All Listed Sponsors
lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT03444480 - A Phase Ⅰb Study of Remimazolam Tosylate in Healthy Volunteers | Biotech Hunter | Biotech Hunter